BNT162b2 mRNA Vaccine for COVID-19

Vaccine Trials

Pfizer Trial Report

Critiques of Trial Protocols

Large Skewed Data Exclusions

Refusal to Release Safety Reports and Raw Data

Pfizer is trying to halt the release of documents studying its vaccine. However, due to a FOIA request submitted by Aaron Siri, some of those documents have been released.

Emergency Use Authorization

Efficacy of BNT162b2

Efficacy in Preventing Death

Efficacy in Preventing Hospitalization

Efficacy in Preventing Infection

Efficacy in Preventing Symptoms

Efficacy in Preventing Transmission

Pharmacovigilance

Marketing

National Contracts

Pfizer has been criticized for an array of strong arm tactics while negotiating contracts for its vaccines with various nations.

https://www.legitgov.org/pfizer-demands-countries-put-military-bases-embassies-and-bank-reserves-collateral-vaccine-injury

Safety

Noteworthy Safety Events

Print/export